JP2022541322A5 - - Google Patents
Info
- Publication number
- JP2022541322A5 JP2022541322A5 JP2022504622A JP2022504622A JP2022541322A5 JP 2022541322 A5 JP2022541322 A5 JP 2022541322A5 JP 2022504622 A JP2022504622 A JP 2022504622A JP 2022504622 A JP2022504622 A JP 2022504622A JP 2022541322 A5 JP2022541322 A5 JP 2022541322A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- patient
- sotagliflozin
- diabetes mellitus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19188477.4A EP3769767A1 (en) | 2019-07-25 | 2019-07-25 | Use of sotagliflozin for the treatment of patients with type 2 diabetes mellitus and moderate renal impairment |
| EP19188477.4 | 2019-07-25 | ||
| PCT/IB2020/057016 WO2021014420A1 (en) | 2019-07-25 | 2020-07-24 | Use of sotagliflozin for the treatment of patients with type 2 diabetes mellitus and moderate renal impairment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022541322A JP2022541322A (ja) | 2022-09-22 |
| JP2022541322A5 true JP2022541322A5 (enExample) | 2023-08-01 |
Family
ID=67438963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022504622A Pending JP2022541322A (ja) | 2019-07-25 | 2020-07-24 | ２型真性糖尿病及び中等度の腎障害を有する患者の治療に対するソタグリフロジンの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220265690A1 (enExample) |
| EP (2) | EP3769767A1 (enExample) |
| JP (1) | JP2022541322A (enExample) |
| CN (1) | CN114222571A (enExample) |
| AU (1) | AU2020319164A1 (enExample) |
| CA (1) | CA3148400A1 (enExample) |
| WO (1) | WO2021014420A1 (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008010959A2 (en) | 2006-07-14 | 2008-01-24 | The Trustees Of The University Of Pennsylvania | Beam ablation lithography |
-
2019
- 2019-07-25 EP EP19188477.4A patent/EP3769767A1/en not_active Ceased
-
2020
- 2020-07-24 EP EP20747477.6A patent/EP4003366A1/en not_active Withdrawn
- 2020-07-24 AU AU2020319164A patent/AU2020319164A1/en not_active Abandoned
- 2020-07-24 CA CA3148400A patent/CA3148400A1/en active Pending
- 2020-07-24 WO PCT/IB2020/057016 patent/WO2021014420A1/en not_active Ceased
- 2020-07-24 US US17/629,166 patent/US20220265690A1/en not_active Abandoned
- 2020-07-24 CN CN202080053637.0A patent/CN114222571A/zh not_active Withdrawn
- 2020-07-24 JP JP2022504622A patent/JP2022541322A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Heller | Weight gain during insulin therapy in patients with type 2 diabetes mellitus | |
| AR047779A1 (es) | Composiciones y metodos para tratar diabetes | |
| NZ710575A (en) | Pharmaceutical compositions for the treatment of diabetes mellitus | |
| WO2001032157A3 (en) | Pharmaceutical composition comprising a combination of metformin and glibenclamide | |
| Tripathy et al. | Trends in diabetes care with special emphasis to medicinal plants: Advancement and treatment | |
| US8507451B1 (en) | Method for the treatment of type II diabetes | |
| CN102940677B (zh) | 治疗糖尿病足的药物组合物 | |
| MX2023001785A (es) | Formulacion compuesta para tratamiento de diabetes mellitus tipo 2. | |
| Mackenzie et al. | Atropine overdose in three children | |
| Beach | Anginal symptoms associated with certain constitutional diseases | |
| CN101347511A (zh) | 具有降血糖作用的药物组合物 | |
| RU2002120168A (ru) | Способ лечения ишемических заболеваний глаз | |
| US4082842A (en) | Medicant composition for the treatment of diabetes | |
| Rachmilewitz et al. | Electrocardiographic changes and the effect of niacin therapy in pellagra | |
| CN104027450B (zh) | 一种治疗糖尿病的中药组合物 | |
| Papazafiropoulou et al. | Diabetes drugs and cardiovascular safety | |
| Kiraz et al. | A very rare side effect of amlodipine: non-cardiogenic pulmonary edema | |
| Pong et al. | Dapagliflozin (Farxiga) for type 2 diabetes mellitus. | |
| CN107029093A (zh) | 一种治疗糖尿病的中药 | |
| Razia et al. | Prescribing Pattern of Oral Anti-diabetic Agents among Patients with Type 2 Diabetes in Outpatient Department of a Tertiary Care Hospital in Bangladesh. | |
| CN1213758C (zh) | 小叶猪殃殃作为治疗糖尿病药的应用 | |
| Monya-Tambi | Insulin lispro/insulin suspension isophane/pioglitazone | |
| CHINTA et al. | COMPARATIVE HYPOGLYCAEMIC ACTIVITY OF FIXED DOSE COMBINATION ANTI-DIABETIC FORMULATIONS VERSUS RESPECTIVE MONOTHERAPIES IN DIABETIC RABBITS | |
| Weintraub | Big Pharma Looks Beyond Insulin Researchers may be on the verge of major new treatments for diabetes and obesity | |
| CN1568952A (zh) | 口服降血糖复方药物制剂 |